Immuneering Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 24.0% | – | – | – | – | – | 50.0% | 293.6% | |
| – | – | – | – | – | -24.0% | – | – | – | – | – | 50.0% | -193.6% | |
| – | – | – | – | – | 2,037.1% | – | – | – | – | – | 3,877.6% | 2,958,627.1% | |
| – | – | – | – | – | 508.6% | – | – | – | – | – | 1,384.2% | 1,301,122.6% | |
| – | – | – | – | – | 2,531.0% | – | – | – | – | – | 5,263.9% | 17,363.7% | |
| – | – | – | – | – | -2,555.1% | – | – | – | – | – | -5,263.9% | -17,583.4% | |
| – | – | – | – | – | -2,485.3% | – | – | – | – | – | -4,784.6% | -15,867.7% | |
| – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -2,485.3% | – | – | – | – | – | -4,784.6% | -15,867.8% | |
| – | – | – | – | – | -2,461.3% | – | – | – | – | – | -4,761.2% | -17,003.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.